Literature DB >> 16839542

Forkhead transcription factors, Foxc1 and Foxc2, are required for the morphogenesis of the cardiac outflow tract.

Seungwoon Seo1, Tsutomu Kume.   

Abstract

Previous studies have shown that Foxc1 and Foxc2, closely related Fox transcription factors, have interactive roles in cardiovascular development. However, little is known about their functional overlap during early heart morphogenesis. Here, we show that Foxc genes are coexpressed in a novel heart field, the second heart field, as well as the cardiac neural crest cells (NCCs), endocardium, and proepicardium. Notably, compound Foxc1; Foxc2 mutants have a wide spectrum of cardiac abnormalities, including hypoplasia or lack of the outflow tract (OFT) and right ventricle as well as the inflow tract, dysplasia of the OFT and atrioventricular cushions, and abnormal formation of the epicardium, in a dose-dependent manner. Most importantly, in the second heart field, compound mutants exhibit significant downregulation of Tbx1 and Fgf8/10 and a reduction in cell proliferation. Moreover, NCCs in compound mutants show extensive apoptosis during migration, leading to a failure of the OFT septation. Taken together, our results demonstrate that Foxc1 and Foxc2 play pivotal roles in the early processes of heart development, especially acting upstream of the Tbx1-FGF cascade during the morphogenesis of the OFT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16839542     DOI: 10.1016/j.ydbio.2006.06.012

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  62 in total

1.  Endothelial cell specification in the somite is compromised in Pax3-positive progenitors of Foxc1/2 conditional mutants, with loss of forelimb myogenesis.

Authors:  Alicia Mayeuf-Louchart; Didier Montarras; Catherine Bodin; Tsutomu Kume; Stéphane D Vincent; Margaret Buckingham
Journal:  Development       Date:  2016-02-02       Impact factor: 6.868

2.  Early lineage restriction in temporally distinct populations of Mesp1 progenitors during mammalian heart development.

Authors:  Fabienne Lescroart; Samira Chabab; Xionghui Lin; Steffen Rulands; Catherine Paulissen; Annie Rodolosse; Herbert Auer; Younes Achouri; Christine Dubois; Antoine Bondue; Benjamin D Simons; Cédric Blanpain
Journal:  Nat Cell Biol       Date:  2014-08-24       Impact factor: 28.824

Review 3.  The neural crest in cardiac congenital anomalies.

Authors:  Anna Keyte; Mary Redmond Hutson
Journal:  Differentiation       Date:  2012-05-15       Impact factor: 3.880

Review 4.  Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations.

Authors:  Mary R Hutson; Margaret L Kirby
Journal:  Semin Cell Dev Biol       Date:  2006-12-19       Impact factor: 7.727

Review 5.  Transcriptional pathways in second heart field development.

Authors:  Brian L Black
Journal:  Semin Cell Dev Biol       Date:  2007-01-17       Impact factor: 7.727

6.  A house with many rooms: how the heart got its chambers with foxn4.

Authors:  Ethan David Cohen; Edward E Morrisey
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

Review 7.  Forkhead transcription factors and cardiovascular biology.

Authors:  Kyriakos N Papanicolaou; Yasuhiro Izumiya; Kenneth Walsh
Journal:  Circ Res       Date:  2008-01-04       Impact factor: 17.367

8.  Foxc1 controls the growth of the murine frontal bone rudiment by direct regulation of a Bmp response threshold of Msx2.

Authors:  Jingjing Sun; Mamoru Ishii; Man-Chun Ting; Robert Maxson
Journal:  Development       Date:  2013-01-23       Impact factor: 6.868

9.  A stem-deuterostome origin of the vertebrate pharyngeal transcriptional network.

Authors:  J Andrew Gillis; Jens H Fritzenwanker; Christopher J Lowe
Journal:  Proc Biol Sci       Date:  2011-06-15       Impact factor: 5.349

10.  Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways.

Authors:  Benjamin E Reinking; Elesa W Wedemeyer; Robert M Weiss; Jeffrey L Segar; Thomas D Scholz
Journal:  Cardiovasc Diabetol       Date:  2009-07-31       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.